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As bactérias do ácido láctico (BAL) são amplamente utilizadas na indústria alimentar. Este 
grupo de microrganismos não só têm a capacidade de produzir ácido láctico, que contribui para 
o sabor e a textura dos produtos fermentados, mas também possuem a capacidade de 
produzir, durante a fermentação do leite, péptidos bioactivos que podem ser importantes para a 
saúde humana por terem actividade anti-hipertensiva, antimicrobiana, antioxidante ou anti 
trombótica. O queijo creme de Chiapas, queijo tradicional mexicano, é obtido através de uma 
coagulação ácida e enzimática prolongada de leite cru de vaca e tem características sensoriais 
únicas devido às BAL endógenas no leite desta região. Assim, o objectivo deste projecto foi 
seleccionar e estudar a bioactividade de isolados altamente hidrolíticos do queijo Chiapas. Uma 
selecção inicial de 84 isolados foi realizada para produção de diacetil e uma produção negativa 
de catalase. Uma análise adicional para medir o grau de hidrólise e para obter o perfil de 
péptidos foi realizada. Os isolados seleccionados foram comparados com Lactobacillus 
helveticus DSM 13137 e utilizados para estudar a actividade potencial dos péptidos libertados 
durante a fermentação láctica. As propriedades antioxidantes de fracções de soro de leite, após 
24h e 48h de fermentação em leite reconstituído desnatado (LRD), foram avaliadas por dois 
métodos espectrofotométricos. Através da captura do radical 2,2´- azinobis (3-
etilbenzotiazolina-6-ácido sulfônico) (ABTS) variou entre 50%-86%, enquanto que pelo ensaio 
do poder antioxidante redutor do ferro apresentou valores de FRAP variáveis entre as amostras 
seleccionadas. Um ensaio de inibição da enzima de conversão da angiotensina (ACE) por 
HPLC foi realizado, mostrando inibições médias de 75% nos isolados em comparação com 
96% em DSM 13137. Os efeitos inibidores potenciais dos péptidos bioactivos produzidos por 
os isolados seleccionados também foram testados contra alguns organismos patogénicos: 
Escherichia coli, Salmonella Typhi, Salmonella Enteritidis e Listeria monocytogenes, usando o 
método de disco de papel e mostrando casos com zonas de inibição de diâmetro de 12 mm, 
em média. Os resultados indicados sugerem que estas estirpes podem ter aplicações como 
starters na indústria de lacticínios e como fonte de novos péptidos bioactivos com diferentes 






















































Lactic acid bacteria (LAB) are widely used in food industry. This group of microorganisms not 
only have the ability to produce lactic acid, which contributes to the taste and texture of 
fermented products but also show the capability to produce, during milk fermentation, bioactive 
peptides that can be important in human health by having antihypertensive, antimicrobial, 
antioxidative, antithrombotic and mineral-binding activities. Chiapas cream cheese, a traditional 
type of Mexican cheese, is obtained through a prolonged acid-enzymatic coagulation of cow 
raw milk and has unique sensory characteristics due to the endogenous LAB in milk from this 
region. Thus, the aim of this project was to select and study the bioactivity of high hydrolytic 
isolates from Chiapas cheese. An initial selection from 84 isolates was made for production of 
diacetyl and a negative production of catalase. Further analysis to measure the degree of 
hydrolysis and to obtain the peptide profile was carried out. Selected isolates were compared to 
Lactobacillus helveticus DSM 13137 and used to study the potential activity of peptides 
released through lactic fermentation. The antioxidant properties of whey fractions, after 24h and 
48h of fermentation in reconstituted skimmed milk (RSM), were evaluated by two 
spectrophotometric methods. Scavenging of the cation radical of 2, 2’-Azino-Bis (3–
Ethylbenzthiazoline–6-Sulfonic Acid) (ABTS) ranged from 50%-86% while ferric reducing 
antioxidant power assay presented variable FRAP values among the selected strains. An 
angiotensin-converting enzyme (ACE) inhibitory assay by HPLC was performed showing 
inhibitions by average mean of 75% in the isolates compared to 96% in DSM 13137. The 
potential inhibitory effects of the bioactive peptides produced by the selected isolates were also 
tested against some food-poisoning pathogenic organisms: Escherichia coli, Salmonella Typhi, 
Salmonella Enteritidis and Listeria monocytogenes, using the paper disc method, showing 
cases with inhibitory zones by average mean of 12 mm diameter zone. The results indicated 
suggest that these strains could have applications as starters in dairy industry and as a source 
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1. Introduction  
 
Due to a growing demand for food with attractive organoleptic characteristics and 
microbiologically safe, the development of new products or improving existing ones has been a 
constant these days [1]. Lactic acid bacteria (LAB) have been widely used by food industries, 
not only as a biopreservative since is one of the oldest and highly efficient forms of non-thermal 
processing method but also to add distinct flavours and aromas to the end product [2, 3].  
 
Cheese is one of the most significant products fermented by these microorganisms. In Mexico, 
cheese-making is one of the most important industries and it uses approximately 25% of the 
total milk produced in the country [4]. While many dairy products, if properly manufactured and 
stored, are biologically, biochemically and chemically very stable, cheese is, in contrast, 
biologically and biochemically active [5].  
 
Artisanal cheeses are usually obtained through a prolonged acid-enzymatic coagulation of cow 
raw milk which has endogenous LAB, adding unique sensory characteristics that vary from 
region to region. Interestingly, it has been reported that some strains of LAB possess 
compelling health-promoting properties through the bioactive peptides they release during milk 
fermentation [6-10].  
 
The traditional fermented products are complex ecosystems, often unknown, which constitute a 
source of new strains of LAB that could be potential sources of new genes encoding variants of 
bacteriocins, proteases and / or other enzymes [5]. 
 
 
1.2. Chiapas cream cheese 
 
Chiapas cream cheese is a traditional ripened cheese from the southern Chiapas state in 
Mexico. It is known for its sour taste and relatively high salt content (5.34%) [11]. During its 
manufacturing, it undergoes a stage of acidification, for several hours at room temperature, by 
native species of lactic acid bacteria, forming a fresh and soft paste. This type of cheese is 
made with cow’s milk, raw or anger, in whole or partially skimmed, from one of the three 
different regions of Chiapas: North, Frailesca (center) and Costa (coast) [11,12]. 
 
This tropical cream cheese enjoys great prestige in the state of Chiapas and Tabasco where it 
is consumed, popularly accompanying the daily food, and has great potential for obtaining a 
PDO (protected designation of origin) [13].  
 
Recently, scientists tried to characterize the endogenous LAB present in Chiapas cheese by 
molecular techniques, showing different dominant genera according to season and region [14]. 
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However there are still limited studies about the potential bioactivity of peptides produced by 
endogenous LAB isolated from this type of cheese. 
 
 
1.3. Lactic Acid Bacteria 
 
Lactic acid bacteria are a wide range of phylogenetically related genera of Gram-positive 
(Figure 1), non-spore-forming bacteria, which produce lactic acid as the major end product of 
sugar fermentation [1, 15]. They are generally catalase and oxidase negative with a rods or 
cocci shape [1].Besides being aerotolerant anaerobes, organisms that tolerates the presence of 
oxygen but does not require it for growth, these microorganisms are mesophiles and have 
complex nutritional requirements especially for amino acid and vitamins [15]. Therefore, they 
require proteolytic systems capable of hydrolysing proteins into peptides or amino acids. For 
example, the Lactococcal proteolytic system consists of enzymes outside the cytoplasmic 
membrane, transport systems, and intracellular peptidases [16].  
 
 
Figure 1. Concensus tree, based on comparative sequence analysis of 16S rRNA, showing major 
phylogenetic groups of lactic acid bacteria with low mol% guanine plus cytosine in the DNA and the 
nonrelated Gram-positive genera Bifidobacterium and Propionibacterium.  
Adapted from Schleifer & Ludwig (1995) [17]. 
 
 
Based on their sugar fermentation patterns, is possible to divide this diverse group in two 
categories: homofermentative (or homolactic) bacteria such as Lactococcus and Streptococcus, 
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which follows the Embden-Meyerhof pathway and results in almost exclusively lactic acid as the 
end product; and heterofermentative (or heterolactic) bacteria, for example Leuconostoc and 
Weissella, which follows the 6-phosphogluconate/phosphoketolase pathway and results in other 
end products such as ethanol, acetic acid and carbon dioxide in addition to lactic acid [1, 3, 15]. 
 
This characteristic is not only useful for their taxonomy, but also in the food industry since 
heterolactics are more relevant in producing flavour and aroma components such as 
acetylaldehyde and diacetyl, than the homolactics [16]. 
 
 
1.3.1. Applications in food industry 
 
Lactic acid bacteria are widespread in nature and are among the most important groups of 
microorganisms used in food fermentation [3]. Although LAB are comprised of 11 genera, only 6 
of them are dairy associated: Lactococcus, Enterococcus, Streptococcus, Leuconostoc, 
Pediococcus, and Lactobacillus [18, 19]. They are involved in making yogurt, cheese, cultured 
butter, beverages, soy sauce, sour cream, and many more [1]. These bacteria not only 
contribute to the development of the desired sensory properties in the final product but are also 
capable of inhibiting food spoilage, increasing its microbiological safety and shelf life [2]. It has 
also been reported the use of LAB to control mould growth as an alternative to the existing 
physical and chemical methods [20].  
 
These abilities can be achieved through two ways: fermentation products, where the 
antimicrobial activity can be exerted through the reduction of pH or production of organic acids 
(lactic acid, acetic acid), CO2, reuterin, diacetyl, 2-pyrorelidone, 5-carboxylic acid (PCA), 
preventing the pathogen and contaminant growth that may occur during cheese making 
process; or through bacteriocins, which can be defined as protein antibiotics of relatively high 
molecular weight and mainly affecting the same or closely related species [21-23].  
 
It is known that LAB are generally regarded as safe microorganisms and so are their 
bacteriocins [22]. Nisin was the first bacteriocin known and used for many years in numerous 
countries as a food additive to extend the shelf-life or to control specific microorganisms such as 
Clostridium spp, Listeria monocytogenes and other Gram-positive pathogens [24, 25]. 
 
Lactobacillus helveticus is traditionally used in the manufacture of Italian cheeses and it is the 
prevalent species recovered from natural lactic starter cultures [26]. These microorganisms help 
enhance the flavour of the cheeses and can help reduce or prevent bitterness. They are also 
gaining importance as health-promoting culture in probiotic and nutraceutical food products [27]. 
It has the potential to produce bioactive peptides or bacteriocins, and exert symbiotic effect 
when associated with prebiotics in fermented dairy products [26, 27]. Lactobacillus 
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helveticus can therefore be considered as a multifunctional LAB with increasing importance in 
the food industry [27]. 
 
 
1.3.2. Probiotic effects in human health 
 
LAB are regarded as a major group of probiotic bacteria [28]. The probiotic concept has been 
defined by Fuller (1989) to mean “a live microbial feed supplement which beneficially affects the 
host animal by improving its intestinal microbial balance” [29]. Lactic acid bacteria have been 
shown to have a positive impact on human health when consumed as viable cells (probiotic). 
Relevant literature reviews have been written with an emphasis on health roles for lactobacilli 
and bifidobacteria in humans and/or animals [29, 30, 31]. These microorganisms colonize the 
intestine and are reported to have different effects. They produce substances inhibitory to 
pathogenic microorganisms, reduce the cholesterol level in the blood serum of pigs and 
alleviate lactose intolerance in V galactosidase deficient persons [32, 33, 34]. They also have 
been shown to have an anti-cancer effect, to stimulate the immune system and lowering blood 
pressure [35].  
 
The blood pressure is mediated through Angiotensin Converting Enzyme (ACE) which plays a 
key role in its regulation. This enzyme is found in the rennin angiotensin system and have been 
reported by several researchers that fermented milk with probiotics LAB can exert ACE 
inhibitory effect [36]. A few commercial functional dairy products enriched with ACE-inhibitory 
peptides such as Evolus® (Valio Ltd. Valio, Finland), Calpis sour milk marketed as Ameal S® 
(Calpis Food Industry Co., Ltd., Tokyo, Japan) and Casein DP-Peptio® (Kanebo Co., Ltd., 
Kanebo, Japan) have been introduced as additional or alternative treatments for hypertension. 
The antihypertensive effects of these milk have been tested in vivo using hypertensive human 
subjects and spontaneously hypertensive rat models [37, 38, 39]. 
 
For these reasons consumption of fermented dairy products has been advocated by some 
physicians, scientists and non-scientists. In fact, lactobacilli are now sold in pharmacies and 









2. Aims of the study 
 
The present project aims at selecting high hydrolytic lactic acid bacteria isolated from Chiapas 
cream cheese and the study of peptides activity released during milk fermentation. The specific 
objectives of this work were: 
 
 To screen all the isolates for biochemical properties and proteolytic performance; 
  
 To investigate the potential activity of the peptides released by selected proteolytic 
strains, with a focus on antioxidant properties, angiotensin-converting enzyme 




















3. Material & Methods 
 
 
3.1. Biological material 
 
For the present study, previously isolated colonies (here designated test bacteria) numbered 
from 1-87 were used. These isolates, listed in Table 1, were obtained from two samples of 
Chiapas cheese represented in Figure 2, through random and selective media based on the 
morphology and Gram staining of lactic acid bacteria. Bacterial isolates were then stored at  
-70ºC in cryovials (Microbank Pro-Lab Diagnostics, South Wirral, England).  
 
Table 1. Codification of isolated colonies stored. 
# code Cheese Medium Atmosphere 
1-6 Tabasco MRS Aerobic 
7-18 Veracruz MRS Aerobic 
19-28 Tabasco MRS Aerobic 
29-35 Tabasco MRS Anaerobic 
36-42 Tabasco MRS Anaerobic 
43-47 Tabasco Blood agar Anaerobic 
48-54 Tabasco Blood agar Anaerobic 
55-60 Veracruz MRS Anaerobic 
61-70 Veracruz MRS Anaerobic 
71-77 Veracruz Blood agar Anaerobic 
79-87 Veracruz Blood agar Anaerobic 
 
 
Figure 2. Origin of the isolates used in this study: Double cream Chiapas cheese from Veracruz (left) and 
Double cream Chiapas cheese from Tabasco (right). 
 
The potential bioactivity of the selected colonies was assessed against six target bacteria: 
Escherichia coli K12, Salmonella enterica serovar Typhi, Salmonella enterica serovar 
Enteritidis, Listeria monocytogenes 10403S, Listeria monocytogenes EGD-e and Listeria 
monocytogenes L028. 
 
Lactobacillus helveticus DSM 13137 was chosen as a comparative reference strain since it is 
predominantly used in the fermentation of milk and has been reported to produce 





Different media containing all the nutrients necessary for the growth of the isolates as well as 
the target organisms were used to perform the assays (Table 2). 
Table 2. Media composition used in this study. 
Identification Composition (g/L) 
De Man, Rogosa, 
Sharpe agar 
(MRSA) 
10g of peptone, 8g of Lab-Lemco powder, 4g of yeast extract, 20g of glucose, 
1mL of sorbitan monooleate, 2g of dipotassium hydrogen phosphate, 5g of 
sodium acetate 3H2O, 2g of triammonium citrate, 0.2g of magnesium sulphate 
7H2O, 0.05g of manganese sulphate 4H2O, 10g of agar 
Brain heart infusion 
broth (BHI) 
12.5g of brain infusion solids, 5g of beef heart infusion solids, 10g of protease 
peptone, 5g of sodium chloride, 2g of glucose, 2.5g of disodium hydrogen 
phosphate 
Brain heart infusion 
agar (BHIA) 
12.5g of brain infusion solids, 5g of beef heart infusion solids, 10g of protease 
peptone, 5g of sodium chloride, 2g of glucose, 2.5g of disodium hydrogen 




100g of skim milk powder for microbiology (Sigma ®) 
 
All media, except RSM, were sterilized by autoclaving at 121°C for 15 minutes and stored at 
5°C. The reconstituted skimmed milk was pasteurized in a steamer for 20 minutes at 100°C and 
used on the same day. 
 
3.3. Initial selection of the isolates 
 
3.3.1. Activation of strains 
 
For activation, the anaerobic strains were streaked with disposable sterile loops on MRSA 
(Oxoid ®, Basingstoke, Hampshire, England) and grown under anaerobic conditions: a mixture 
of CO2, H2 and N2 in a ratio 10:10:80 respectively, in an anaerobic cabinet (Don Whitley 
Scientific Ltd Shipley, West Yorkshire, UK) for 48 h at 37 ºC. The aerotolerant strains were also 
streaked on MRSA and grown in an incubator for 48h at 30ºC.  
 
3.3.2. Milk fermentation and sampling 
 
The milk fermentations were carried out in hungate tubes (16x125mm) with 15mL of 10% (w/v) 
RSM. To each tube, an inoculum of 1% of a fresh overnight culture in BHI of the testing strain 
was added, in order to reach an initial number of 106-107 cells/mL, except in the negative control 
that only contained the pre-culture medium. The fermentations were performed in duplicates 
and incubated at 30°C under continuous agitation for 24h.  
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After the fermentation, the pH of each tube was measured using a pH-meter SevenEasy 
(Mettler-Toledo AG 8603, Switzerland) to ensure acidification has occurred. Samples of 4mL of 
each replicate were taken to determine the diacetyl production, total amount of proteins, degree 
of hydrolysis (DH) and peptide profile. These samples were heated up at 72°C for 1 minute to 
stop the enzymatic proteolysis and then centrifuged at 13000 rpm for 10 minutes. The 
supernatant was recovered, filtered through 0.45μm sterile filter (Minisart High-Flow, Sartorius, 
Germany) and stored at -25°C for further analysis. 
 
3.3.3. Catalase test 
 
With a sterile disposable loop, a small amount of a well isolated, 18 to 24 hours old colony from 
MRSA was transfered onto the surface of a clean microscope slide. Two drops of 3% hydrogen 
peroxide were added onto the smear. A positive result was a rapid evolution of O2 by bubbling, 
while no bubbles was considered a negative result. 
 
3.3.4. Diacetyl test 
 
Diacetyl production was determined according to King (1948) as followed: 1 mL of milk 
previously inoculated with strains cultures (1%, v/v, incubation for 24 h at 30 °C) was mixed with 
0.5 mL of a α-naphthol (1%, w/v in ethanol), followed by 0.5 mL of KOH (16% w/v) and 
incubated at 30 °C for 10 minutes [41]. Diacetyl production was indicated by a development of 
pink colour in the tubes, while no change of colour was considered as negative.    
 
3.3.5. Total amount of proteins and degree of hydrolysis 
 
The total amount of proteins in each sample was determined using bicinchoninic acid (Sigma-
Aldrich). Twenty parts of bicinchoninic acid solution were mixed with one part of 4% (w/v) 
copper (II) sulfate pentahydrate solution before the analysis. Two millilitres of the reagent 
solution were added to 0.1mL of milk sample (soluble fraction) and incubated at 37°C for 30 
minutes. Serial dilutions of bovine serum albumin (Sigma-Aldrich) were used as standard and 
the blank consisted only of buffer with no protein. The absorbance was read at 562nm within 10 
minutes of each other using a spectrophotometer Ultrospec 1100 Pro UV/Vis (Amersham, 
Uppsala, Sweden). This assay was performed in duplicate. The standard curve was used to 
calculate the final protein concentration in mg/mL, multiplied by any dilution factor that was 
required to make in order to bring the concentration within the linear range of the assay.  
The degree of hydrolysis (DH) was determined using the method of o-phthaldialdehyde (OPA) 
described by Nielsen et al. (2001) with some modifications [42]. Samples were previously 
diluted in deionised water to reach a concentration of 0.1-1mg/mL. 200μL of diluted fermented 
milk sample were added to 1.5 mL of OPA reagent (Sigma-Aldrich) in an assay tube and after 2 
minutes incubation the absorbance was immediately read, using 2mL acrylic cuvettes, at 340nm 
in a spectrophotometer (Ultrospec 1100 Pro UV/Vis, Amersham). Deionised water was used as 
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a blank and a serine dilution (0.9516 meqv/L) was used as standard. The DH was calculated 
using the following equation (3.3.5.1): 
% = × 100 (3.3.5.1) 
 
Where DH% is the percentage of degree of hydrolysis and h, the number of hydrolysed bonds, 






where α, β and htot with the values 0.4, 1 and 8.8 respectively, are constants for whey described 
by Nielsen et al. (2001) [38]. htot is the total number of peptide bonds per protein equivalent.  
 
In order to calculate Serine-NH2 the next formula (3.3.5.3) was used: 
− 2 =
( )





where Serine-NH2= meqv.serine NH2.g
-1 protein;  S= sample volume (L); D= dilution factor;  
P= protein concentration of the sample (g/L). This assay was also carried out in duplicate. 
 
3.3.6. Peptide Profile  
 
The peptide profile was determined by RP-HPLC (reversed-phase high performance liquid 
chromatography) using a gradient described by Gonzalez et al. (2013) as followed: a mobile 
phase of solvent B (Trifluoroacetic acid 0.08% in acetonitrile) was run from 0 to 40% in 60 min, 
40–70% in 5 min, 70–70% in 10 min, and 70–0% in 5 min, following a wash out of 100% of 
solvent A (Trifluoroacetic acid 0.1% in water) for 15 min [43]. The flow rate was 0.8 mL/min 
through a column (Ace 5 C18 250 × 4.6 mm 5 mm, 100 Å), reading at a wavelength of 214 nm. 
All the samples were filtered throughout sterile filters of 0.22μm (Ministart High-Flow) and 
injected two times into the Dionex HPLC system (Figure 3). This system consisted of an ASI-
100 T automated sample injector, a photodiode array detector, PDA-100 and a computer with 











Figure 3. Dionex HPLC system used in this study. 
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3.4. Bioactivity assays 
 
3.4.1. Milk fermentations and sampling 
 
After the initial selection of the isolates, three strains were selected for the bioactivity studies. 
Milk fermentations were carried out in duplicate, in glass Schotts, with 100mL of 10% (w/v) 
reconstituted skimmed milk. An inoculum of 3% (v/v) of a fresh overnight culture in BHI of the 
selected strain as well as Lactobacillus helveticus DSM13137 was added, in order to reach an 
initial number of 106-107 cells/mL, except in the negative control that only contained the pre-
culture medium. The glass bottles were incubated at 30°C under continuous agitation for 48 
hours. 
 
Samples of 5mL were taken after 0h, 24h and 48h of fermentation with sterile disposable 
graduated pipettes under aseptic conditions by the Bunsen burner. These samples were heated 
up at 72°C for 1 minute to stop the enzymatic proteolysis and then centrifuged at 13000rpm for 
10 minutes. The supernatant was recovered, filtered through 0.45μm sterile filter (Minisart High-
Flow, Germany) and stored at -25°C for further analysis.  
 
3.4.2. Angiotensin-converting enzyme (ACE) inhibitory activity 
 
The ACE-inhibitory activity percentage (ACEi%) was determined according to the method 
described by Gonzalez et al. (2011) [44]. It is a method based on the reaction of hydrolysis of N-
Hippuryl-His-Leu (HHL) into hippuric acid (HA) and His-Leu (HL) catalysed by the angiotensin-
converting enzyme (ACE). The activity of ACE was measured in terms of HA produced over 
time. 10μL of fermented milk sample was added to 30μL of ACE (60 mU, Sigma-Aldrich) and 
incubated at 37°C for 10 minutes, before 90 μL of 5mM HHL was added. After gently mixing it in 
a vortex it was incubated for 60 minutes at 37ºC. The reaction was ended using 8μL 5M HCl 
and the samples were filtered throughout sterile filters of 0.22μm (13mm, Kinesis®) into screw 
top vials (Conex chromatography systems, Scotland). 
The concentration of HA produced at the end of the reaction was determined by reversed-phase 
high performance liquid chromatography (RP-HPLC) according to Mehanna and Dowling (1999) 
with some minor modifications [45]. A column Ace 5 C18 250×4.6 mm 5 mm, 100 Å (Advanced 
Chromatography Technologies, Scotland) was used in a Dionex HPLC system which consisted 
of an ASI-100 T automated sample injector, a photodiode array detector, PDA-100 and a 
computer with the Chromeleon v6.8 Sunnyvale datasystem software (all from Dionex Softron 
GmbH, Germany). A sample of 20 μL was injected into the system. The flow rate was 1 mL/min 
with an isocratic solution of acetonitrile 12.5% and trifluoroacetic acid 0.1% in water over 20 
minutes and the area peaks corresponding to the HA concentration were obtained at 228nm 
absorbance. ACEi% assays were made by duplicate and each sample was injected two times 
into the HPLC system.  
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The ACEi% was calculated by subtracting the HA produced in the presence of the inhibitors to 
the HA produced in absence of inhibitors (under the same conditions) as shown below (3.4.2.1): 
% =
[ ] [ ]
[ ]
× 100 (3.4.2.1) 
 
where HAc is the concentration of hippuric acid produced by the ACE incubated in milk at 30°C 
for 0, 24 and 48h without the inoculum. This control was found to be more appropriate for this 
study than buffer as it reduced any interference from other components in the milk such as 
calcium that may induce inhibition [46]. HAs is the concentration of hippuric acid produced by 
the ACE in the presence of inhibitors contained in the fermented milk. 
 
3.4.3. Ferric reducing antioxidant power (FRAP) 
 
The FRAP assay is based on the reduction of Fe(III)  to Fe(II) due to the action of antioxidants 
present. Subsequently, the Fe(II) formed may interact with 2,4,6-tris(2pyridyl)-s-triazine (TPTZ) 
providing a strong absorbance at 595nm [47].  
 
This assay was performed according to Benzie & Strain (1996) with minor modifications [48]. 
FRAP reagent was prepared as a mixture of 2.5 mL of 10 mM TPTZ in 40 mM HCl and 2.5 mL 
of 20 mM FeCl3 in 25 mL of 0.1 M acetate buffer (pH= 3.6). 10 μL of a fermented milk sample 
was mixed with 300μL of the FRAP reagent into a microcentrifuge tube. After gently mixing it in 
a vortex, 100μL were transferred in duplicate into a 96-well plate.  Absorbance was measured 
immediately after in the plate reader (Tecan GENios) at 595nm.  
 
Serial dilutions of ascorbic acid (Sigma-Aldrich) were used as standard and the calibration curve 
obtained (R2 ≥0.99) was used for quantification. 
 
3.4.4. Trolox equivalent antioxidant capacity (TEAC) 
 
The trolox equivalent antioxidant capacity (TEAC) assay is based on the scavenging of the  
2,2'-azinobis-(3-ethylbenzothiazoline-6-sulfonic acid) (ABTS) radical converting it into a 
colourless product. The degree of decolourization induced by a compound is related to that 
induced by trolox, giving the TEAC value [49].  
 
In this assay, a solution of ABTS+ • radical was prepared by mixing 5mL of 7mM stock solution 
of ABTS with 88μL of 140mM potassium persulfate. The mixture was kept in the dark at room 
temperature for at least 16h prior to use. This solution was then diluted in phosphate buffer 
sulphate (PBS) until an absorbance of 0.700 ± 0.020 was reached at λ=734nm. 20µL of each 
milk fermented sample were added in Eppendorf tubes, in triplicate, followed by 2mL of the 
solution previously prepared. After 6 minutes in the dark, the mixture was transferred into a 
cuvette and the absorbance was read at λ=734nm in a spectrophotometer.   
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Trolox standards were used for quantification and data was expressed as µmol Trolox 




× 100 (3.4.4.1) 
 
where ABScontrol is the absorbance of ABTS radical diluted in PBS and ABSsample is the 
absorbance of the reaction with the sample. 
 
3.3.5. Antimicrobial assay 
 
In order to obtain the cell-free extracts, each testing strain was cultivated in sterile flasks (20 
mL) with 15 mL of BHI and incubated at 30°C under continuous agitation (200 rpm). After 24h, 
each culture was centrifuged for 3 minutes at 10000 rpm in order to get a supernatant which 
was then filtered through 0.22 μm filter (Ministart Highflow, Germany) and freezed at -25°C for 
future use. The pH values of the supernatants were neutralized to 6.8 by 0.1 NaOH to ensure 
that zones of inhibition were not the result of lactic acid production. 
 
An overnight culture in BHI broth of the target organisms was also performed. Standardized 
inoculums (1x108 CFU/mL) were lawned onto sterile BHIA by swabbing evenly with sterile 
cotton swabs in three different directions. 6 mm sterile paper discs (Whatman, N3) were 
impregnated with 10μL of the supernatant and placed aseptically and distinctively onto the 
inoculated BHI agar plates (Figure 4), in duplicate. As a control, sterile BHI broth was absorbed 
in a disc and placed on BHIA plate. The agar plates were then incubated at 30ºC for 18h.  
 
The sensitivities of the microorganisms to the supernatants were determined by measuring the 
sizes of inhibitory zones (including the diameter of disc) on the agar surface with a ruler. 
 
 




3.5. Molecular analysis 
 
3.5.1. DNA extraction from pure cultures  
 
In order to extract and purify the DNA of the isolates, a loopful of cells (from agar plates) was 
added to 0.5mL TES buffer. After mixing it with a vortex, 10µL lysozyme (10mg/mL) and 2µL 
mutanolysin (1mg/mL) were added to the cell suspension and incubated in a waterbath at 37°C. 
After 30 minutes, 10µL proteinase K (20mg/mL) and 10µL RNase (10mg/mL) were added to the 
cell suspension, separately, and the tube was incubated at 65°C for 1 hour. After incubation, 
100µL of 10% SDS (sodium dodecyl sulfate) was added to the samples and incubated for 15 
minutes more at the same temperature. The samples were then allowed to cool on ice for 30 
minutes. Under a fume hood, 620µL phenol:chloroform:water was added and the contents of 
the tubes were gently mixed by inversion for 2 minutes. The samples were then centrifuged for 
10 minutes at 6500 rpm. The aqueous (upper) layer was transferred to a clean and sterile 
microcentrifuge tube, using a wide-bore pipette tip. 1mL of ice-cold ethanol was added to the 
aqueous layer and after the contents were mixed, the samples were left on ice and stored 
overnight in a -20°C freezer. On the following day, the samples were centrifuged for 5 minutes 
at 13000 rpm and the supernatant was carefully removed. The tubes were inverted on a paper 
towel and allowed to dry for at least 3 hours. DNA was re-suspended in 50µL of sterile water 
and stored at -20°C. 
 
DNA concentration and purity of each sample was then measured with a NanoDrop™ 





Isolates were subjected to random amplified polymorphic DNA (RAPD) analysis in order to 
estimate their genetic variations.  
 
The reaction mixture (25μL) consisted of 5μL GoTaq Flexi buffer (5x), 2.5μL dNTPs (0.4 mM of 
each of dATP, dCTP, dGTP, dTTP), 1.5μL MgCl2, 1μL primer (20pmol/mL), 1μL GoTaq DNA 
polymerase (Promega), 1μL template DNA (5 ng/μL) and 13μL mili-Q water. The mixture was 
then incubated in the thermocycler (with heating lid) programmed for 40 cycles, each one 
consisting of a denaturation step (30 seconds at 94°C), one annealing step (60 seconds at 
38°C) and an extension step (2 minutes at 72°C), an extra extension step was performed for 10 
min at 72°C. The amplification was carried out with primer OPA-09 (5’-GGGTAACGCC-3’). The 
reaction products were separated by electrophoresis on an agarose gel (1.5%) containing 
ethidium bromide with final concentration of 0.5ng/mL prepared in 1X TAE buffer. A 1Kb DNA 
ladder was used as a molecular size indicator. DNA fragment (bands) patterns were then 




3.5.3. Bifidobacterium specific PCR 
 
Although selective media for Lactobacillus was used in the bacterial isolation, a PCR with 
Bifidobacterium genus-specific primer sets Bif164-f (5’-GGGTGGTAATGCCGGATG-3’) and 
Bif662-GC-r (5’-CGCCCGCCGCGCGCGGCGGGCGGGG-3’) was performed. 
The reaction mixture consisted of 5μL GoTaq Flexi buffer (5x), 2.5μL dNTPs mix, 1μL of each 
primer (both 20pmol/mL), 1μL GoTaq DNA polymerase (Promega), 0.5μL template DNA (5 
ng/μL) and 14μL mili-Q water. The PCR thermocycling program with primers Bif164-f and 
Bif662-GC-r was the following: 94°C for 5 minutes; 35 cycles of 94°C for 30 seconds, 58°C for 
20 seconds, 68°C for 40 seconds; and 68°C for 7 minutes. The reactions were subsequently 
cooled to 4°C. The size and amounts of PCR products were estimated by analysing 5µl 
samples by 2% agarose gel electrophoresis in 1x TAE buffer and ethidium bromide staining 





























4. Results & Discussion 
 
4.1. Initial selection of the isolates 
 
An initial screening of 84 isolates from Chiapas cheese was performed for their ability to 
produce diacetyl and their absence of catalase activity. The catalase test has been used for 
many years for rapid differentiation of the genera of Gram-positive organisms and it is 
associated to pathogen species of Enterobacteriaceae [50]. The detection of diacetyl is an 
indicator of yeast or lactic acid bacteria presence [51].  Based on these two characteristics, a 
total of 24 isolates (19 from Tabasco and 5 from Veracruz cheese sample) were selected and 
used for further studies. A detailed board can be consulted in Appendix A (Page 25-26).  
 
The total amount of proteins present in the fermentation samples of the selected isolates was 
then quantified using the bicinchoninic acid (BCA) method. The results showed concentrations 
by average mean between 3-12 mg/mL throughout the selected isolates, using bovine serum 
albumin (BSA) as a whey protein standard. This assay has a good combination of sensitivity 
and simplicity, being more accurate than other well-known protein determination methods such 
as Lowry or Bradford, especially due to the complex stability [52].  An accurate measurement of 
protein concentration was critical since the results were also used to determine the degree of 
hydrolysis.  
 
Amino acids in protein molecules are linked together through amide bonds or peptide bonds 
[53]. During hydrolysis, these bonds are delinked or cleaved to produce peptides [54]. The 
percentage of the peptide bonds cleaved, or degree of hydrolysis, was determined based on a 
reaction between amino groups and OPA in the presence of DTT.  
 
In Figure 5, seven isolates that revealed a similar or higher degree of hydrolysis than 
Lactobacillus helveticus DSM13137 (12.28%) are presented as well as the amount of protein 
measured in each sample.  
 
Figure 5. Degree of hydrolysis and total amount of protein present in samples of Lactobacillus helveticus 







DSM13137 43 48 46 12 28 10 6
Degree of Hydrolysis (%) Total Amount of Protein (mg/mL)
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Although the degree of hydrolysis describes how much a protein substrate has been modified 
by an enzyme, a correlation between the total amount of protein and the hydrolysis degree is 
not absolutely necessary [42]. 
 
These results were confirmed by RP-HPLC analysis. The peptide profiles of the twenty four 
isolates were obtained, and the isolates with a higher degree of hydrolysis showed a higher 
number of peaks with different patterns while the samples with less than 5% DH almost showed 
any peaks, for example the strain 76 in Figure 6 did not reveal peptide release compared to 
strain 10 that have shown a degree of hydrolysis of 18% and is showing a significant amount of 




Figure 6. Comparison between degree of hydrolysis and peptide profile of sample 76 and 10. 
 
From these results, the isolates 6, 10 and 12 showed a high degree of hydrolysis (>12.28 
DH%), and therefore considered as highly hydrolytic isolates were selected to perform the 
bioactivity studies. 
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4.2. Bioactivity studies 
 
4.2.1. ACE inhibitory activity 
 
After a new set of fermentations, extracts of fermented samples from the chosen isolates were 
screened for ACE inhibition, as presented in Figure 7. The calibration curve obtained with 
hippuric acid can be consulted on Appendix B (Page 27). 
 
 
Figure 7. Results of ACE inhibitory activity in fermentation samples of three strains (6, 10, 12) of Chiapas 
cheese and DSM13137. 
 
At 0h fermentation, fermented milk interestingly showed 40.3% inhibition throughout the 
isolates. This could be due to the production of ACE-inhibitory peptides during the pre-culture 
medium or/and because the samples were only taken after the inoculation of all the strains in 
milk, which took at least 15 minutes. It has also been reported that unfermented milk apparently 
exhibited slight ACE inhibitory activity and the ACE inhibitory activity was markedly increased 
throughout fermentation by probiotics LAB [55]. 
 
During fermentation, the percentage of ACE inhibition in samples with the selected isolates 
increased continuously reaching a maximum at 24h fermentation, with values between 76-79%.  
 
On the other hand, Lactobacillus helveticus DSM13137 showed an increasing %ACE inhibitory 
activity after 24h. At 48h of fermentation, it was observed the highest ACE inhibitory activity 
(96.5%) in this study. These results are in accordance with earlier reports performed by 
Gonzalez (2011) [44].  
These results clearly indicate that fermentation plays an important role in the release of ACE 
inhibitory compounds by these microorganisms. 
Although the samples of the isolates did not show an inhibition higher than the comparative 























the artificially synthesized ACE-inhibitory drugs (vasodilators, diuretics, calcium channel 
blockers, angiotensin II receptor blockers and ACE-inhibitors such as captopril, enalapril, 
alecepril, lisinopril) [36]. 
 
4.2.2. Antioxidant activity 
 
The antioxidative potential of LAB has been reported in several studies but a single mechanism 
or compound associated with it has not been able to distinguish [56, 57]. As various methods 
are used to test the antioxidant activity the results are expressed in a variety of ways which 
makes comparison difficult. 
 
In this study, the antioxidant properties of the fermented samples were evaluated by two 
different methods: ferric reducing antioxidant power (FRAP) and trolox equivalent antioxidant 
capacity (TEAC).  
 
FRAP values were obtained by comparing the absorbance change at 595 nm in test reaction 
mixtures with those containing ferrous ions in known concentration. The values clearly 
increased with fermentation time due to the formation of the complex, as presented in Figure 8. 
A calibration curve obtained with ascorbic acid can be consulted on Appendix B (Page 27). 
 
 
Figure 8. FRAP activity measured after 0, 24 and 48h of fermentation of three strains (6, 10, 12) of 
Chiapas cheese and DSM13137. 
 
Higher FRAP values give higher antioxidant capacity because FRAP value is based on reducing 
ferric ion, where antioxidants are the reducing agent. Hence, these strains should be able to 
donate electrons to free radicals stable in the actual biological and food system. According to 
Hodzic et al. (2009), FRAP assay had been used to determine antioxidant activity as it is simple 
and quick [58]. Besides that, the reaction is reproducible and linearly related to molar 







































Through the TEAC assay, the antioxidant activity was measured by the ability of whey to 
scavenge ABTS.+ cation radicals. In this method, the extent of scavenging of a preformed free 
radical relative to that of a standard antioxidant compound (Trolox, an analogue of Vitamin E) is 
determined.  
 
The antioxidant activity of the different isolates varied between 292 and 1700µmol·L−1 (TEAC), 
as presented in Figure 9. A calibration curve with different known concentrations of Trolox can 
be consulted on Appendix B (Page 27). 
 
 
Figure 9. Results of TEAC assay in fermentation samples of three strains (6,10, 12) of Chiapas cheese 
and DSM13137. 
 
All cell free samples showed highly scavenging potential against ABTS radical cation, ranging 
from 50 to 86%. The maximum activity was observed with DSM13137(comparative strain) after 
48h of fermentation, followed by strain 6 (83.5%) as presented in Figure 10.  
 
Figure 10. Results of antioxidant activity in fermentation samples of three strains (6, 10, 12) of chiapas 
cheese and DSM13137. 
 
Both methods showed that antioxidant activity increased in all strains during fermentation. The 
milk fermented by Lactobacillus helveticus DSM 13137, which exhibited an intermediate 
proteolytic activity (DH 12%), the lowest between these three testing bacteria, showed the 





























































those reported by Virtanen et al. (2006) which revealed the relationship between the 
development of antioxidant activity and a high degree of proteolysis [59].  
 
Also, since the bacterial cells and most casein were removed from fermented samples these 
results confirm that the antioxidant activity obtained is originated from cell lysis products, 
extracellular metabolites or hydrolysed milk components. 
 
4.2.3. Antimicrobial activity 
 
The selected strains were examined according to their antimicrobial activity. For this purpose, 
cell-free neutral supernatant broths of these isolates were assessed against the different 
indicator microorganisms: Escherichia coli K12, Salmonella enterica serovar Typhi, Salmonella 
enterica serovar Enteritidis, Listeria monocytogenes 10403S, Listeria monocytogenes EGD-e 
and Listeria monocytogenes L028.   
 
The diameter of inhibition zones (Table 3) showed that not all the isolates have antibacterial 
effect on the target microorganisms. Positive results are highlighted in grey.  
 
Table 3. Results of the antimicrobial activity of 7 unknown strains isolated from Chiapas cheese and 
Lactobacillus helveticus DSM 13137. 
 10403S EGD-e L028 K12 TYPHI ENTERITIDIS 
6 - - - 12.0±0.1 10.2±0.1 12.1±0.1 
10 - - - - - - 
12 - - - - - - 
28 - - - - - - 
43 - 10.0±0.1 - - 8.0±0.1 12.0±0.1 
46 - 8.2±0.1 - - 10.1±0.1 10.0±0.1 
48 - - - - - - 
DSM13137 - - - - - - 
 
After 18h, strain 6 showed resistance to Escherichia coli K12, Salmonella enterica serovar 
Enteritidis and Salmonella Typhi, and strain 43 and 46 showed resistance to Listeria 
monocytogenes EGD-e, Salmonella Typhi and Salmonella Enteritidis. These results suggest 
that at least three strains isolated from Chiapas cheese have the ability to produce bacteriocins 
or other bioactive peptides with antimicrobial activities. 
 
Although disc diffusion is a good method to screen the ability of potential metabolites to inhibit 
bacterial growth, it has some drawbacks. The interpretation of the results is mainly visual not 
having in consideration the activity undetected by the naked eye and also is based on the 
assumption that all metabolites diffuse freely in the solid nutrient medium which may lead to 
inaccurate assessment of bacterial susceptibility. 
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4.3 Molecular analysis 
 
Although identification of the isolates was not performed in due time, a random amplified 
polymorphic DNA (RAPD) PCR was performed in order to identify genetic variation. This 
procedure detects nucleotide sequence polymorphisms in a DNA amplification-based assay 
using only a single primer of arbitrary nucleotide sequence [60]. In this reaction, a single 
species of primer binds to the genomic DNA at two different sites on opposite strands of the 
DNA template. If these priming sites are within an amplifiable distance of each other, a discrete 
DNA product is produced through thermocylic amplification. The polymorphisms between 
individuals result from sequence differences in one or both of the primer binding sites, and are 
visible as the presence or absence of a particular RAPD band [60]. 
 
In this study, the selected primer was OPA-09 and a dendogram with the RAPD-PCR patterns 
of each isolate is presented in Figure 11. The 84 isolates were organized in clusters according 
to the similarity of band profiles.  
 
RAPD analysis only allows a qualitative assessment of the DNA effects and the nature of the 
changes in profiles can only be speculated unless amplicons are analysed (with sequencing, 
probing, etc.). Highlighted in blue are groups of isolates that could possibly be replicas of the 
same strain due to the similar band pattern obtained. 
 
For a long time bifidobacteria have been considered relatives to lactobacilli, and the correlation 
was supported by the analysis of the murein structure [62]. In addition they shared other 
characteristics such as being Gram-positive, nonspore-forming, anaerobic, catalase negative 
and the ability to produce acid. However, Poupard et al. (1973) and other researchers were the 
first to postulate that they are more related to Actinomyces, which has been confirmed by 
analysis of 16S rRNA sequences [63, 64]. 
 
A Bifidobacterium genus specific PCR was performed but no bands with the expected size were 
found, hence no isolates belonged to this group as expected. The primer set used have a 
correspondence close to 100% in some studies being highly specific for its group [65]. The 




Figure 11. Dendogram of RAPD-PCR patterns with primer OPA-09 of 84 unknown isolates from Chiapas 






















































































With the characterization methods chosen it was possible to limit our focus on 24 isolates (from 
the 84). The determination of the degree of hydrolysis showed 7 strains with a better activity 
than Lactobacillus helveticus DSM13137. From the three isolates studied, strain 6 was the most 
promising. Not only revealed high antioxidant activity and the ability to produce ACE inhibitors 
during milk fermentation but also showed activity against pathogenic bacteria. The applications 
of these bacteria could be as starters in dairy industry due to their high hydrolytic profile and as 
preventing human diseases in which free radicals are involved, such as cancer, cardiovascular 
disease, and aging or even for cheese preservation. The search for natural ACE inhibitors as 
alternatives to synthetic drugs is of great interest to prevent several side effects, and bioactive 
peptides are one among the best alternatives which can be developed as potential 
pharmaceutical ACE inhibitors.  
 
Although further studies and identification of the strains would be beneficial in the future, it is 
clear that traditional fermented products constitute a source of new strains of LAB that could be 
applied in functional and/or pharmaceuticals due to their properties.  
 
Furthermore, the dairy industry which uses Lactobacillus species as starter cultures in dairy 
products, should work closely with the medical professionals in order to substantiate the health 























6. Future directions 
 
Lactic acid bacteria seem to be promising candidates in the preparation of nutraceuticals. 
Therefore, identification and/or modification of endogenous lactic acid bacteria from artisanal 
products with improved properties for this purpose is an obvious future objective.  
 
Additional studies to these isolates should be performed in order to: identify the predominant 
peptides in the hydrolysates; stability to digestion - with a view to determine if the hydrolysates 
when subjected to simulating gastrointestinal conditions still show high activity. Also, 
antihypertensive peptides are only minor constituents in highly complex food matrices and, 
therefore, a monitoring of the large-scale production by hydrolytic or fermentative industrial 

































Appendix A  
 


















1 Tabasco Aerobic - - * * 
2 Tabasco Aerobic - + 3.737±0.004 11.26±0.06 
3 Tabasco Aerobic - - * * 
4 Tabasco Aerobic - - * * 
5 Tabasco Aerobic + + * * 
6 Tabasco Aerobic - + 12.500±0.003 23.64±0.12 
7 Veracruz Aerobic + - * * 
8 Veracruz Aerobic + - * * 
9 Veracruz Aerobic - - * * 
10 Veracruz Aerobic - + 6.300±0.001 18.02±0.01 
11 Veracruz Aerobic + - * * 
12 Veracruz Aerobic - + 6.638±0.006 14.99±0.02 
13 Veracruz Aerobic + - * * 
15 Veracruz Aerobic - - * * 
16 Veracruz Aerobic - - * * 
17 Veracruz Aerobic - - * * 
18 Veracruz Aerobic - - * * 
19 Tabasco Aerobic - - * * 
21 Tabasco Aerobic + - * * 
22 Tabasco Aerobic - - * * 
23 Tabasco Aerobic - - * * 
24 Tabasco Aerobic - - * * 
25 Tabasco Aerobic - - * * 
26 Tabasco Aerobic - - * * 
27 Tabasco Aerobic - + 3.30±0.005 12.20±0.01 
28 Tabasco Aerobic - + 4.688±0.004 15.32±0.04 
29 Tabasco Anaerobic - - * * 
30 Tabasco Anaerobic - - * * 
31 Tabasco Anaerobic - + 6.650±0.009 1.17±0.01 
32 Tabasco Anaerobic - + 7.313±0.004 3.42±0.03 
33 Tabasco Anaerobic - + 5.600±0.008 2.62±0.03 
34 Tabasco Anaerobic - - * * 
35 Tabasco Anaerobic - + 5.088±0.009 6.20±0.05 
36 Tabasco Anaerobic - + 4.675±0.006 5.06±0.02 
37 Tabasco Anaerobic - - * * 
38 Tabasco Anaerobic - - * * 
39 Tabasco Anaerobic - + 3.280±0.003 7.99±0.06 
40 Tabasco Anaerobic - + 3.063±0.001 6.19±0.05 
41 Tabasco Anaerobic - - * * 
42 Tabasco Anaerobic - - * * 
43 Tabasco Anaerobic - + 3.263±0.006 14.03±0.05 
44 Tabasco Anaerobic - + 3.688±0.009 11.63±0.05 
45 Tabasco Anaerobic - + 5.150±0.005 10.58±0.04 
46 Tabasco Anaerobic - + 5.538±0.006 14.51±0.05 
47 Tabasco Anaerobic - - * * 
48 Tabasco Anaerobic - + 4.375±0.003 14.28±0.05 
49 Tabasco Anaerobic - - * * 
50 Tabasco Anaerobic - + 3.813±0.008 7.30±0.02 
51 Tabasco Anaerobic - + 4.525±0.005 5.72±0.03 
52 Tabasco Anaerobic - - * * 
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Samples 14, 20 and 78 showed no growth therefore they were not used in this project. 

























53 Tabasco Anaerobic - - * * 
54 Tabasco Anaerobic - - * * 
55 Veracruz Anaerobic - - * * 
56 Veracruz Anaerobic - - * * 
57 Veracruz Anaerobic - - * * 
58 Veracruz Anaerobic - - * * 
59 Veracruz Anaerobic - - * * 
60 Veracruz Anaerobic - - * * 
61 Veracruz Anaerobic - - * * 
62 Veracruz Anaerobic - - * * 
63 Veracruz Anaerobic - - * * 
64 Veracruz Anaerobic - - * * 
65 Veracruz Anaerobic - - * * 
66 Veracruz Anaerobic - - * * 
67 Veracruz Anaerobic - - * * 
68 Veracruz Anaerobic - - * * 
69 Veracruz Anaerobic - - * * 
70 Veracruz Anaerobic - - * * 
71 Veracruz Anaerobic - + 3.35±0.003 8.29±0.02 
72 Veracruz Anaerobic - - * * 
73 Veracruz Anaerobic - - * * 
74 Veracruz Anaerobic - - * * 
75 Veracruz Anaerobic - + 3.421±0.008 5.30±0.05 
76 Veracruz Anaerobic - + 4.863±0.008 0.33±0.05 
77 Veracruz Anaerobic - - * * 
79 Veracruz Anaerobic - - * * 
80 Veracruz Anaerobic - - * * 
81 Veracruz Anaerobic - - * * 
82 Veracruz Anaerobic - - * * 
83 Veracruz Anaerobic - - * * 
84 Veracruz Anaerobic - - * * 
85 Veracruz Anaerobic - - * * 
86 Veracruz Anaerobic - - * * 







Figure 12. Calibration curve of Trolox in TEAC assay. 
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Ascorbic Acid concentration (µmol/L) 
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